John T. Piazza

486 total citations
6 papers, 264 citations indexed

About

John T. Piazza is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John T. Piazza has authored 6 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John T. Piazza's work include HER2/EGFR in Cancer Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Phosphodiesterase function and regulation (2 papers). John T. Piazza is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Phosphodiesterase function and regulation (2 papers). John T. Piazza collaborates with scholars based in United States, China and Germany. John T. Piazza's co-authors include Lawrence Lum, Rubina Tuladhar, Yunku Yeu, Xiaofeng Wu, Tae Hyun Hwang, Jean R. Clemenceau, David H. Mathews, Zhen Tan, James Kim and Christopher P. Mill and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

John T. Piazza

6 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John T. Piazza United States	4	217	45	41	27	18	6	264
Taylor K. Loe United States	6	196 0.9×	39 0.9×	35 0.9×	15 0.6×	14 0.8×	8	321
Joe Harman United Kingdom	8	245 1.1×	32 0.7×	16 0.4×	33 1.2×	49 2.7×	12	321
Rubina Tuladhar United States	8	373 1.7×	65 1.4×	55 1.3×	28 1.0×	40 2.2×	9	447
Santhosh Palani United States	9	272 1.3×	35 0.8×	37 0.9×	31 1.1×	30 1.7×	11	353
Amina Boussouar France	8	285 1.3×	66 1.5×	30 0.7×	43 1.6×	18 1.0×	8	368
Megumi Yoshida Japan	7	281 1.3×	56 1.2×	42 1.0×	21 0.8×	29 1.6×	19	370
Natalia V. Varlakhanova United States	11	352 1.6×	70 1.6×	45 1.1×	24 0.9×	60 3.3×	15	425
Barun Mahata India	9	206 0.9×	19 0.4×	28 0.7×	15 0.6×	10 0.6×	12	264
Hongwen Chen United States	10	211 1.0×	14 0.3×	29 0.7×	19 0.7×	23 1.3×	14	277
Julie Carnesecchi France	11	253 1.2×	100 2.2×	44 1.1×	15 0.6×	19 1.1×	17	337

Countries citing papers authored by John T. Piazza

Since Specialization

Citations

This map shows the geographic impact of John T. Piazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Piazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Piazza more than expected).

Fields of papers citing papers by John T. Piazza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Piazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Piazza. The network helps show where John T. Piazza may publish in the future.

Co-authorship network of co-authors of John T. Piazza

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Piazza. A scholar is included among the top collaborators of John T. Piazza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Piazza. John T. Piazza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Mill, Christopher P., et al.. (2022). The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein. Pharmacological Reviews. 74(1). 18–47. 41 indexed citations

2.

Piazza, John T., Kanupriya Whig, Ling Zhai, et al.. (2020). Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics. PLoS ONE. 15(12). e0243901–e0243901. 2 indexed citations

3.

Tuladhar, Rubina, Yunku Yeu, John T. Piazza, et al.. (2019). CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation. Nature Communications. 10(1). 147 indexed citations

4.

Wu, Xiaofeng, Jason E. Toombs, Yi-Chun Kuo, et al.. (2017). Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor. Nature Cell Biology. 19(10). 1226–1236. 38 indexed citations

5.

Zhu, Bing, Nan Li, Kevin Lee, et al.. (2017). Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling. Oncotarget. 8(41). 69264–69280. 34 indexed citations

6.

Russo, Suzanne, Li Nan, Kevin Lee, et al.. (2014). Phosphodiesterase 10, a novel target in colon cancer.. Journal of Clinical Oncology. 32(3_suppl). 503–503. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact